@article{MA Lopez-Hernandez_M Alvarado_J De Diego_Borbolla-Escoboza_RM Jimenez_E Trueba_2004, place={Pavia, Italy}, title={A randomized trial of dexamethasone before remission induction, in de novo childhood acute lymphoblastic leukemia}, volume={89}, url={https://haematologica.org/article/view/3013}, DOI={10.3324/%x}, abstractNote={We evaluated the impact of adding dexamethasone before chemotherapy in 95 children with de novo standard-risk acute lymphoblastic leukemia (ALL). The children were randomly divided into 2 groups: one group was given dexamethasone, the other was not. The initial characteristics and mean follow-up of both groups were similar. Day +14 blast percentage was significantly lower in the dexamethasone group. Disease-free survival at 40-months follow-up was better (almost significantly so) in the dexamethasone group.}, number={3}, journal={Haematologica}, author={MA Lopez-Hernandez and M Alvarado and J De Diego and Borbolla-Escoboza and RM Jimenez and E Trueba}, year={2004}, month={Mar.}, pages={365-366} }